Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
A Multicentre, Open-label, Prospective Long-term Study Evaluating the Clinical Benefit and
Effectiveness of SEROQUEL XR® (Quetiapine Fumarate Extended-Release Tablets) in Subjects with
Schizophrenia.